TY - JOUR
T1 - Discrepancies Between Autofluorescence Imaging Modalities in CNGB3-Associated Achromatopsia and Correlation With Ellipsoid Zone Continuity.
AU - HN, Akhtar
AU - CFJ, Lam
AU - Lin, S
AU - Arno, G
AU - JS, Pulido
AU - AR, Webster
AU - Michaelides, M
AU - OA, Mahroo
PY - 2025/5/17
Y1 - 2025/5/17
N2 - PurposeTo explore discrepancies on fundus autofluorescence (FAF) obtained with two widely used devices in patients with CNGB3-associated achromatopsia, with respect to the central foveal signal. Secondly, to explore continuity of the foveal ellipsoid zone (EZ) in these patients.MethodsPatients who had undergone blue (488 nm; Heidelberg Spectralis) and green (532 nm; Optos) FAF imaging during the same visit were included. The central foveal signal was graded qualitatively as brighter or darker compared to the wider foveal/parafoveal region. Optical coherence tomography images from the same visit were also graded (masked to FAF grading) with respect to foveal EZ continuity.ResultsForty-one patients (24 females; mean age, 32 ± 19 years) were included. For blue FAF, the central foveal signal was graded darker in all cases. For green FAF, the central fovea was brighter in 11 patients (27%), indicating discordance with blue FAF. The discordant group were significantly younger (P = 0.022). The EZ line was gradable in 40 patients: 22 (55%) had continuous foveal EZ in both eyes; these were younger than those with an interrupted EZ in one or both eyes (P < 0.0001). All patients discordant for FAF images had continuous foveal EZ.ConclusionsDiscordance occurred between the FAF modalities in more than one-quarter of patients; these patients were significantly younger, and all had a continuous EZ line. Investigating mechanisms of discordance could yield pathophysiological insights.Translational relevanceFAF platforms are not interchangeable; these findings could inform the design of natural history studies and therapeutic trials for this condition.
AB - PurposeTo explore discrepancies on fundus autofluorescence (FAF) obtained with two widely used devices in patients with CNGB3-associated achromatopsia, with respect to the central foveal signal. Secondly, to explore continuity of the foveal ellipsoid zone (EZ) in these patients.MethodsPatients who had undergone blue (488 nm; Heidelberg Spectralis) and green (532 nm; Optos) FAF imaging during the same visit were included. The central foveal signal was graded qualitatively as brighter or darker compared to the wider foveal/parafoveal region. Optical coherence tomography images from the same visit were also graded (masked to FAF grading) with respect to foveal EZ continuity.ResultsForty-one patients (24 females; mean age, 32 ± 19 years) were included. For blue FAF, the central foveal signal was graded darker in all cases. For green FAF, the central fovea was brighter in 11 patients (27%), indicating discordance with blue FAF. The discordant group were significantly younger (P = 0.022). The EZ line was gradable in 40 patients: 22 (55%) had continuous foveal EZ in both eyes; these were younger than those with an interrupted EZ in one or both eyes (P < 0.0001). All patients discordant for FAF images had continuous foveal EZ.ConclusionsDiscordance occurred between the FAF modalities in more than one-quarter of patients; these patients were significantly younger, and all had a continuous EZ line. Investigating mechanisms of discordance could yield pathophysiological insights.Translational relevanceFAF platforms are not interchangeable; these findings could inform the design of natural history studies and therapeutic trials for this condition.
UR - https://www.scopus.com/pages/publications/105006949774
U2 - 10.1167/tvst.14.5.24
DO - 10.1167/tvst.14.5.24
M3 - Article
C2 - 40423615
SN - 2164-2591
VL - 14
JO - Translational vision science & technology
JF - Translational vision science & technology
IS - 5
M1 - 24
ER -